Jasper Therapeutics, Inc
Jasper Therapeutics, Inc. is a biotechnology company headquartered in Redwood City, California, dedicated to developing innovative therapies for chronic mast cell-driven diseases. With a focus on mast cell depletion, the company is working on its lead product, briquilimab, a targeted anti-KIT monoclonal antibody, to treat conditions such as chronic spontaneous urticaria and allergic asthma.
The management team at Jasper comprises seasoned biopharma veterans with extensive experience in drug development and commercialization, positioning the company to effectively bring new treatments to market. By collaborating with leading academic institutions and leveraging cutting-edge research, Jasper aims to enhance the safety and efficacy of therapies for patients suffering from chronic immunological and inflammatory conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.